BEATRICE LOPEZ: Open Payments
NPI 1184813693 · LIGONIER, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$466 in 26 payments from 13 companies in 2025. Trend: 2023 $672 · 2024 $404 · 2025 $466
Food & beverage: $466
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $94 |
| ABBVIE INC. | 5 | $92 |
| Lilly USA, LLC | 3 | $49 |
| Abbott Laboratories | 2 | $38 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $37 |
| Exact Sciences Corporation | 2 | $30 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $22 |
| Xeris Pharmaceuticals, Inc. | 1 | $20 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
Products named: VRAYLAR, Wegovy, JARDIANCE, FREESTYLE LIBRE 3, MOUNJARO, Cologuard Collection Kit, XIFAXAN, GVOKE HYPOPEN.
Industry payments across IN — which companies pay providers there.
